Insiders · Profile

Lin Patrick

Chief Business - Strategy Off at Processa Pharmaceuticals. Filing since 1 Oct 2020. CIK 0001799363

Company

Date

Role

Action

Shares

Amount

Of holding

PCSA Processa Pharmaceuticals, Inc.

30 Jun 2026

Chief Business - Strategy Off

Bought

2,106

$4.06K

19.1%

PCSA Processa Pharmaceuticals, Inc.

15 Jun 2026

Chief Business - Strategy Off

Bought

1,831

$4.06K

20.0%

PCSA Processa Pharmaceuticals, Inc.

29 May 2026

Chief Business - Strategy Off

Bought

1,582

$4.07K

20.8%

PCSA Processa Pharmaceuticals, Inc.

15 May 2026

Chief Business - Strategy Off

Bought

1,369

$4.07K

22.0%

PCSA Processa Pharmaceuticals, Inc.

30 Apr 2026

Chief Business - Strategy Off

Bought

1,511

$4.06K

32.0%

PCSA Processa Pharmaceuticals, Inc.

15 Apr 2026

Chief Business - Strategy Off

Bought

1,369

$4.07K

40.8%

PCSA Processa Pharmaceuticals, Inc.

31 Mar 2026

Chief Business - Strategy Off

Bought

1,603

$4.06K

91.4%

PCSA Processa Pharmaceuticals, Inc.

27 Jan 2025

Chief Business - Strategy Off

Bought

43,500

$34.69K

opened

PCSA Processa Pharmaceuticals, Inc.

1 Feb 2024

Chief Business - Strategy Off

Bought

1,500

$3.60K

5.8%

PCSA Processa Pharmaceuticals, Inc.

31 Jan 2024

Chief Business - Strategy Off

Bought

2,500

$5.93K

10.6%

PCSA Processa Pharmaceuticals, Inc.

17 May 2022

Chief Business - Strategy Off

Bought

2,000

$3.19K

0.5%

PCSA Processa Pharmaceuticals, Inc.

7 Apr 2022

Chief Business - Strategy Off

Bought

800

$2.84K

0.2%

PCSA Processa Pharmaceuticals, Inc.

6 Apr 2022

Chief Business - Strategy Off

Bought

1,200

$3.75K

0.3%

PCSA Processa Pharmaceuticals, Inc.

14 Dec 2021

Chief Business - Strategy Off

Bought

6,000

$24.00K

1.4%

PCSA Processa Pharmaceuticals, Inc.

3 Dec 2021

Chief Business - Strategy Off

Bought

3,500

$16.80K

0.8%

PCSA Processa Pharmaceuticals, Inc.

26 Aug 2021

Chief Business - Strategy Off

Bought

4,000

$24.09K

1.0%

PCSA Processa Pharmaceuticals, Inc.

21 Jun 2021

Chief Business - Strategy Off

Bought

2,000

$13.30K

0.5%

PCSA Processa Pharmaceuticals, Inc.

1 Oct 2020

Chief Business - Strategy Off

Bought

31,250

$65.63K

8.5%

18 decisions on file.